Personalizing breast cancer chemo: does genetic chaos predict success?
NCT ID NCT03096418
Summary
This study aims to understand why a standard chemotherapy drug (paclitaxel) works better for some breast cancer patients than others. It will enroll 50 women with breast cancer who are scheduled to receive this drug before surgery. Researchers will measure drug levels in the body and analyze tumor samples to see if cancers with high 'chromosomal instability' (a type of genetic chaos) respond better to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa Health Care/Holden Comprehensive Cancer Center
NOT_YET_RECRUITINGIowa City, Iowa, 52242, United States
Contact
-
University of Wisconsin Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.